We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+23.01%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$900M
Cap. Flow
+$775M
Cap. Flow %
39.93%
Top 10 Hldgs %
51.62%
Holding
194
New
73
Increased
41
Reduced
31
Closed
42

Top Buys

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$24.5M
2
PPD
PPD, Inc. Common Stock
PPD
+$19M
3
OM icon
Outset Medical
OM
+$18.6M
4
AFIB
Acutus Medical Inc
AFIB
+$16.2M
5
VCEL icon
Vericel Corp
VCEL
+$14.9M

Top Sells

Rank Stock Value
1
LHCG
LHC Group LLC
LHCG
+$8.66M
2
INSP icon
Inspire Medical Systems
INSP
+$8.51M
3
LIVN icon
LivaNova
LIVN
+$7.29M
4
OSUR icon
OraSure Technologies
OSUR
+$6.64M
5
BSX icon
Boston Scientific
BSX
+$6.44M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Industrials 0.76%
3 Consumer Staples 0.45%
4 Energy 0.25%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CUTR
101
DELISTED
Cutera, Inc.
CUTR
$3.48M 0.18%
+183,275
New +$2.83M
CORT icon
102
CALL
Corcept Therapeutics
CORT
$12.1B
$3.29M 0.17%
+188,900
New +$3.01M
RCL icon
103
CALL
Royal Caribbean
RCL
$82.4B
$3.24M 0.17%
+50,000
New +$2.94M
STXS icon
104
Stereotaxis
STXS
$139M
$3.23M 0.17%
902,275
– –
KURA icon
105
Kura Oncology
KURA
$882M
$3.13M 0.16%
+102,066
New +$2.25M
ATRC icon
106
CALL
AtriCure
ATRC
$2.22B
$2.99M 0.15%
+75,000
New +$3.18M
KRMD icon
107
KORU Medical Systems
KRMD
$152M
$2.95M 0.15%
408,516
-21,400
-5% -$190K
VAPO
108
PUT
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$2.9M 0.15%
+12,500
New +$3.6M
DIN icon
109
CALL
Dine Brands
DIN
$462M
$2.73M 0.14%
+50,000
New +$2.53M
INCY icon
110
CALL
Incyte
INCY
$24.5B
$2.69M 0.14%
30,000
-21,000
-41% -$2.03M
LYRA
111
DELISTED
LYRA THERAPEUTICS INC
LYRA
$2.54M 0.13%
4,534
+574
+14% +$357K
GNMK
112
PUT
DELISTED
GenMark Diagnostics, Inc
GNMK
$2.48M 0.13%
+175,000
New +$2.67M
BCRX icon
113
BioCryst Pharmaceuticals
BCRX
$2.71B
$2.48M 0.13%
721,919
+285,419
+65% +$1.22M
AVTR icon
114
Avantor
AVTR
$9.42B
$2.36M 0.12%
+105,000
New +$2.18M
CSII
115
CALL
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.36M 0.12%
+60,000
New +$1.94M
FOLD
116
DELISTED
Amicus Therapeutics
FOLD
$2.23M 0.12%
158,200
+55,900
+55% +$815K
ARDX icon
117
Ardelyx
ARDX
$1.03B
$2.2M 0.11%
418,908
+22,367
+6% +$134K
QDEL icon
118
PUT
QuidelOrtho
QDEL
$1.02B
$2.19M 0.11%
+10,000
New +$2.23M
CLDX icon
119
Celldex Therapeutics
CLDX
$3.52B
$2.14M 0.11%
144,200
-105,900
-42% -$1.24M
BMY.RT
120
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.99M 0.1%
886,222
+424,600
+92% +$1.21M
RAPT
121
DELISTED
RAPT Therapeutics
RAPT
$1.61M 0.08%
+6,250
New +$1.39M
CHAQ.U
122
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
$1.58M 0.08%
153,960
– –
FPRX
123
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.52M 0.08%
322,452
+311,352
+2,805% +$1.58M
INO icon
124
PUT
Inovio Pharmaceuticals
INO
$79.6M
$1.51M 0.08%
+10,858
New +$2.26M
PSTX
125
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1.32M 0.07%
+148,949
New +$1.69M
3 4
5
6 7

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2020 Portfolio in Review

As of Q3 2020, Pura Vida Investments held 194 positions worth $1.94B, up 87% from $1.04B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pura Vida Investments deployed $775M of net new capital in Q3 2020, opening 73 new positions and adding to 41 existing holdings. Its largest new stake was Cooper Companies: 320,000 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was LHC Group LLC, an estimated $8.66M trimmed.

  • Pura Vida Investments's largest Q3 2020 buy was Cooper Companies: 320,000 shares worth $27M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q3 2020, an estimated $11.6M increase.
  • Pura Vida Investments's biggest Q3 2020 reduction was LHC Group LLC, cutting an estimated $8.66M.
  • Pura Vida Investments fully exited LivaNova in Q3 2020, selling an estimated $7.29M.
  • Pura Vida Investments's ten largest holdings make up 52% of its $1.94B portfolio in Q3 2020.
  • Pura Vida Investments opened 73 new positions and closed 42 in Q3 2020.
  • Pura Vida Investments's portfolio value rose 87% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.